Showing 1-10 of about 30807 articles.
Mission Ready Solutions Inc.
VANCOUVER, British Columbia, Aug. 15, 2019 (GLOBE NEWSWIRE) -- Mission Ready Solutions Inc. (“Mission Ready” or the “Company”) (TSXV: MRS) announces an upcoming investor presentation webcast...
LifeVantage Corporation
Reports Highest Annual Revenue in Company History Fiscal 2019 Revenue Increased 11% and Adjusted EBITDA Increased 22% Exceeds High End of Fiscal 2019 Adjusted EPS Guidance SALT LAKE CITY, Aug. 14,...
Gevo, Inc.
ENGLEWOOD, Colo., Aug. 14, 2019 (GLOBE NEWSWIRE) -- Gevo, Inc. (NASDAQ: GEVO) today announced financial results for the second quarter of 2019 and recent corporate highlights. Recent Corporate...
Onconova Therapeutics, Inc.
NEWTOWN, Pa., Aug. 14, 2019 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), a Phase 3 stage biopharmaceutical company discovering and developing novel products to treat cancer, with...
Reeds, Inc.
NORWALK, Conn., Aug. 13, 2019 (GLOBE NEWSWIRE) -- Reed’s Inc. (Nasdaq:REED), owner of the nation’s leading portfolio of handcrafted, all-natural beverages, today announced financial results for the...
Myriad Genetics, Inc.
Total Fourth-Quarter Revenues of $215.4 MillionFourth-Quarter Diluted EPS of ($0.06) and Adjusted EPS of $0.41 SALT LAKE CITY, Aug. 13, 2019 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN,...
Greenlane
BOCA RATON, Fla., Aug. 12, 2019 (GLOBE NEWSWIRE) -- Greenlane Holdings, Inc. (Nasdaq: GNLN) (“Greenlane” or “the Company”), one of the largest global sellers of premium cannabis accessories, CBD and...
Malibu Boats, Inc.
LOUDON, Tenn., Aug. 08, 2019 (GLOBE NEWSWIRE) -- Malibu Boats, Inc. (Nasdaq: MBUU) announced today that it will release its fourth quarter and full-year fiscal 2019 financial results on Thursday,...
Nature's Sunshine Products, Inc.
Second Quarter 2019 Highlights Net sales decreased 0.6 percent to $90.7 million from $91.3 million in the prior yearGAAP net income was $2.6 million compared to a net loss of $0.1 million in the...
MacroGenics, Inc.
Rockville, MD, Aug. 08, 2019 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal...
Showing 1-10 of about 30807 articles.
